Page last updated: 2024-10-28

hydroxychloroquine and Carcinoma, Ductal, Breast

hydroxychloroquine has been researched along with Carcinoma, Ductal, Breast in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durmaz, EÖ1
Atalar, B1
Sezer, E1
Özyar, E1
Çetin, ED1

Other Studies

1 other study available for hydroxychloroquine and Carcinoma, Ductal, Breast

ArticleYear
Cutaneous lupus erythematosus induced by radiotherapy for breast carcinoma.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2019, Volume: 17, Issue:8

    Topics: Adult; Breast; Breast Diseases; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Thera

2019